Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-22-000044

President and CEO gave up 1,715 shares (to pay taxes)

  • President and CEO acquired 89,415 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kramer Robert · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Grant or award : show line 1 in the form +33,833 193,102 D
2022-03-01 Grant or award : show line 2 in the form +55,582 248,684 D
2022-02-28 Shares withheld for taxes : show line 3 in the form −1,715 $39.64 $67,983 246,969 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Grant or award : show line 4 in the form Employee Stock Options (Right to Buy) +135,330 $41.38 $5,599,955 135,330 D
Loading xslF345X03/wf-form4_164626713300332.xml…